Home

The Joint International Oncology Congress convened the Sentinel Node Oncology Foundation’s (SNOF) 5th International Symposium on Cancer Metastasis and the Lymphovascular System: Basis for Rational Therapy and the 8th International Sentinel Node Society (ISNS) Meeting, from Monday, May 27 – Wednesday, May 29, 2013, in San Francisco, California.

Building on the success of recent Sentinel Node Oncology Foundation (SNOF) biennial meetings in San Francisco, New York, and previous ISNS Global meetings, we convened the most renowned international faculty and leading experts in the field of oncology and cancer research, advancing our goal of fostering genuine translational dialogue among the disciplines responsible for discovering and delivering therapies for cancer.

Updates in the understanding of cancer metastases, especially sentinel node biopsy concepts and technology, were the focus of the meeting. Studies of biomarkers and their diagnostic and prognostic applications in cancer progression and metastatic cancer, as well as their usefulness in radioimaging and molecular targeted therapy will be a significant part of the Congress. Recent developments in understanding the cancer microenvironment, the molecular mechanisms involved in the progression of cancer cells to metastasis, and immune trafficking and responses to cancer cells were explored. Results of recent clinical trials of emerging therapies were enthusiastically discussed.

The Congress brought together 300 basic scientists, oncologists, surgeons, and radiologists from around the world, resulting in a cross-fertilization of ideas that will enhance the translation of basic science into clinical application—and challenge basic scientists with clinical issues—thus linking “the bench to the bedside.”

In addition to our regular sessions, this year’s program faetured distinguished guest lectures, mini-symposia, and poster exhibits—including proffered abstract presentations from general audience abstract submission and award-winning abstracts from young investigators and trainees in the field of sentinel node biopsy and cancer metastasis.

We are confident that this 3-day CME-certified activity in San Francisco has made a significant impact by expanding the understanding and practices of oncologists involved in the management of cancer and bringing the clinical relevance of cancer metastasis to the basic scientists.

Thank you for your consideration.

Armando E. Giuliano, MD, FACS, FRCSEd President, International Sentinel Node Society

Armando E. Giuliano, MD, FACS, FRCSEd
President, International Sentinel Node Society

 

Stanley P. L. Leong, MD, FACS President, Sentinel Node Oncology Foundation

Stanley P. L. Leong, MD, FACS
President, Sentinel Node Oncology Foundation